Pipeline Moves: Novo Nordisk progression prospects drop after candidate terminated
This week on Pipeline Moves, we kick off by looking at Novo Nordisk’s acquired candidate belcesiran which the company has…
This week on Pipeline Moves, we kick off by looking at Novo Nordisk’s acquired candidate belcesiran which the company has…
This week on Pipeline Moves, we start by looking at Alnylam’s Phase III win with Amvuttra in ATTR amyloidosis with…
This week on Pipeline Moves, we kick off by looking at the completion of a Phase III trial of BioTissue's…
This week on Pipeline Moves, we kick off by looking at the completion of a Phase II/III trial of Pfizer’s…
This week on Pipeline Moves, we kick off by looking at a Phase III trial of GlycoMimetics’ uproleselan sodium which…
This week on Pipeline Moves, we kick off by looking at the completion of a Phase III trial by Corcept…
This week on Pipeline Moves, we kick off by looking at the termination of a Phase II investigator-led trial of…
This week on Pipeline Moves, we kick off by looking at a Phase III trial completion of Pfizer’s influenza vaccine…
This week on Pipeline Moves, we kick off by looking at a Phase II trial of Noema Pharma’s NOE-105 in…
This week on Pipeline Moves, we kick off by looking at success of a Phase III trial of Ironwood Pharmaceuticals’…